Strategic Fund Product Prices: Anti-Malarial Medicines (valid until 31-Dec-2020)
Long Term Agreement valid until 31 December 2020
1. The prices published reflect the price of the product
2. For budgeting purposes PAHO suggests Member States add an additional 15-25% to reflect the costs of shipping, insurance, 3% contribution to the SF capital account and the 1.25% PAHO fee.
3. Medicines not included in this list, can be purchase individually upon request by Member States. Prices and lead-time will depend on the product availability at the time of the request.
4. Questions should be directed to firstname.lastname@example.org.